These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 28365132)

  • 1. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
    Syn NL; Wang L; Chow EK; Lim CT; Goh BC
    Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer exosomes as next-generation cancer immunotherapy.
    Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
    Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of exosomes as a nanoscale cancer vaccine.
    Tan A; De La Peña H; Seifalian AM
    Int J Nanomedicine; 2010 Nov; 5():889-900. PubMed ID: 21116329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes-Small Players, Big Sound.
    Gulei D; Irimie AI; Cojocneanu-Petric R; Schultze JL; Berindan-Neagoe I
    Bioconjug Chem; 2018 Mar; 29(3):635-648. PubMed ID: 29369619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory Nanomedicine.
    Bartneck M
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28383783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic approach to exosome-based translational nanomedicine.
    Hood JL; Wickline SA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):458-67. PubMed ID: 22648975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
    Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N
    Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy.
    Mukherjee A; Bisht B; Dutta S; Paul MK
    Acta Pharmacol Sin; 2022 Nov; 43(11):2759-2776. PubMed ID: 35379933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial exosomes for translational nanomedicine.
    Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
    J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
    Alfonsi R; Grassi L; Signore M; Bonci D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-based anticancer vaccines: From Bench to bedside.
    Zhao G; Wang Y; Xing S; Jiang Y; Ding J; Cai Y; Ma P; Miao H; Fang Y; Jiang N; Cui D; Yu Y; Tang Q; Wang S; Li N
    Cancer Lett; 2024 Jul; 595():216989. PubMed ID: 38825162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes as novel therapeutic nanodevices.
    Delcayre A; Le Pecq JB
    Curr Opin Mol Ther; 2006 Feb; 8(1):31-8. PubMed ID: 16506523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.